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Background and Aims. The study was a repeated evaluation of the experience of capsule endoscopy (CE) in patients with cardiac
pacemaker or implantable cardioverter deﬁbrillator (ICD). Patients and Methods. A standardized questionnaire was sent by the
manufactorsGivenImagingandOlympustoallcentersinGermany,Austria,andSwitzerlandprovidingcapsuleendoscopyservice.
The questionnaire covers the number of examined patients, monitoring during CE, check of the electric implants before and after
CE, occurrence of arrhythmia, quality of CE video, complications, indication of CE, and type of institution. Results. Overall 580
questionnaires were sent to the users. 26/5% (Germany/Austria + Switzerland) of the questionnaires were sent back anonymously
to the authors. 114 centers (82 hospitals, 11 surgeries, 21 without speciﬁcation) replied. In 58 centers (51%), patients with cardiac
pacemaker (n = 300) and ICDs (n = 80) underwent uneventful capsule endoscopy. The predominant indication (patients with
CP 97%, patients with ICD 100%) was mid gastrointestinal bleeding. Conclusion. The results of our inquiry show that in spite of
formal contraindication CE is increasingly applied in bleeding patients with cardiac pacemakers/ICDs and seems to be safe even
in a large cohort.
1.Introduction
During the last decade, capsule endoscopy (CE) has become
anestablishedtoolfortheinvestigationofthesmallintestine.
However, the US Food and Drug Administration (FDA) as
wellasthemanufactorsGivenImagingandOlympuscontin-
uetorecommendnotusingCEinpatientswithcardiacpace-
makers and implantable cardioverter deﬁbrillators (ICDs).
Our in vitro investigations [1, 2] and several retrospective
cohort studies [3, 4] did not reveal interference between
capsule endoscopy and several types of pacemakers or ICDs,
respectively. A survey in 2004 documented that CE had been
applied in Germany in some patients with implanted cardiac
devices in spite of formal contraindication and appeared to
be safe [3]. In the meantime, two additional investigations
for possible interference between CE and PMs or ICDs
were published [5, 6]. This present survey reevaluates the
clinical practice concerning CE in patients with pacemakers
and ICDs in Germany. Additionally, centers in Austria and
Switzerland were included. Furthermore, the inﬂuence of
relevant publications on the use of CE in patients with pace-
makers and ICDs is evaluated.
2. Methods
A standardized questionnaire was prepared and sent by





Control of cardiac device before CE
Yes 16 (G)
No 34 (G =33, A/S = 1)
No reply to this question 8 (G = 7, A/S = 1)
Control of cardiac device after CE
Yes 28 (G = 27, A/S = 1)
No 27 (G = 26, A/S = 1)
No reply to this question 3 (G)
ECG during CE
Yes 29 (G = 28, A/S = 1)
No 24 (G)
No reply to this question 5 (G = 4,A/S = 1)
CE on ICU
Yes 8 (G = 7, A/S = 1)
No 47 (G)
No reply to this question 3 (G = 2, A/S = 1)
Disturbance of video
Yes 4 (G)




Yes 2 (G; SVES, VES)
no 56 (G = 54, A/S = 2)
Other complications
Yes 0
No 57 (G = 56, A/S = 1)
No reply to this question 1 (A/S)
Indication of CE
Bleeding 54 (G = 52, A/S = 2)
Inﬂammatory bowel disease 1 (G)
Other 2 (G)
No reply to this question 1 (G)
All (with und without application of CE, n = 114)
Type of institution
(all G: 109, A/S: 5)
Hospital 82 (G = 78, A/S = 4)
Outpatient clinic 11 (G)
No reply to this question 21 (G = 20, A/S = 1)
Modiﬁcation of application of CE
Yes 30 (G)
No 44 (G = 43, A/S = 1)
No reply to this question 40 (G = 36, A/S = 4)
CE: capsule endoscopy, ECG: electrocardiogram, ICU: intensive care unit,
G: Germany, A: Austria, S: Switzerland.
capsuleendoscopysystemsinhospitalsandoutpatientclinics
in Germany (G), Austria (A), and Switzerland (S). The cen-
ters were asked to answer the 9 (A, S) or 10 questions (G),
respectively, within 6 weeks anonymously. Corresponding to
the survey in 2004 [3], the items polled included the number
of CE performed in patients with pacemakers and ICDs,
check of the devices before and after CE, monitoring during
CE (ECG, intensive care unit), possible interference between
CE and cardiac pacemakers/ICDs, observed arrhythmias
during CE, adverse events during CE, indication for CE, the
inﬂuence of publications on the application of CE in patients
with pacemakers and ICDs, and ﬁnally country and type
of institution (hospital/outpatient clinic). The questionnaire
in Germany additionally evaluated the participation of the
center in our survey of the year 2004.
3. Results
Given Imaging and Olympus sent a total of 580 question-
naires, 483 questionnaires in Germany (Given Imaging: 312
hospitals, 129 outpatient clinics; Olympus: 42 hospitals) and
97 questionnaires in Austria and Switzerland (Given Imag-
ing: Austria 13 hospitals, Switzerland 39 hospitals, 24 outpa-
tients clinics; Olympus: Austria 13 hospitals, Switzerland 7
hospitals, 1 outpatient clinics). The return of questionnaires
amounted to 22.6% in Germany (109 of 483 questionnaires),
in Austria and Switzerland to 5% (5 of 97 questionnaires).
Fifty-eight centers (51%) used CE in patients with pacemak-
ersorICDs,82ofthemwerehospitals(72%,G =78,A/S =4)
and 11 outpatient clinics (10%, G). Twenty-one of the users
did not reveal their type of institution (18%; G = 20, A/S =
1). In this survey, the number of reported CE patients with
a pacemaker is 300 (Germany n = 286, Austria/Switzerland
n = 14);thecumulativenumberofreportedCEpatientswith
an ICDs is 80 (Germany n = 75, Austria/Switzerland n = 5).
Monitoring was done before CE in 16 patients (G), during
CE in 29 (G = 28, A/S = 1), and after CE in 28 patients (G =
27, A/S = 1), respectively. In 8 clinics, patients underwent CE
on the intensive care unit (ICU). Impairment of the quality
of the CE video, artefacts or recording gaps of the video
after installation of telemetry, was reported by 4 clinics. In
two patients (supra-/ventricular) premature beats without
clinical symptoms were observed. No complications were
reported. Prevailing indication for CE was obscure GI bleed-
ing (97% of the patients with a pacemaker, all patients with
an ICD).
Twenty-six percent of the physicians reported that their
decision to perform CE in patients with a pacemaker or an
ICD had been positively inﬂuenced by relevant publications.
No change in the approach to these patients was reported by
39% of the physicians, and 35% did not give further details
to this question (Table 1). Three of the physicians (2.7%)
had participated in our survey in the year 2004, 90 (86.6%)
answered this question negatively, and 16 (14.7%) provided
no information.
4. Discussion
Several studies and case reports about interference between
pacemakers and ICDs have been published since our survey
in the year 2004 [2, 4–9].
One group reported about interference with pacemakers
and ICDs [10, 11]. For their in vivo and in vitro studies,
a dedicated test cap (Given Imaging, Yoqneam, Israel) wasGastroenterology Research and Practice 3
used to simulate radio transmission of a PillCam. This test
cap caused the pacemaker to revert to noise-mode function
(VOO- or DOO-Mode) and provoked oversensing of ICDs.
However, these ﬁndings could not be reproduced by others
when using original capsule endoscopes in vitro and in
vivo, and several case reports and series reported uneventful
capsule endoscopy in an increasing number of patients
with pacemakers or cardioverters. Furthermore, interference
between CE (Given Imaging) and pacemakers seems to be
impossible from a technical point of view (low emitted
power of CE) even if CE and pacemakers/ICDs are in close
proximity (personal communication by Professor Dr. Silny,
head of research center for electromagnetic environment
compatibility, RWTH Aachen, Germany, based on conﬁden-
tialtechnicaldataprovidedbyGivenImaging).Summarizing
the existing data, it may be concluded that CE seems to
be safe even in the presence of implanted cardiac devices
[12]. Correspondingly, 26% of the physicians reported in
this survey that recent publications had reassured them not
to withhold CE from these patients anymore, regardless of
pacemakers and ICDs still being a formal contraindication.
A limitation of the present survey is the lack of informa-
tion concerning the types and brands of the pacemakers and
ICDs. However, increasing the time load to answer a more
detailed questionnaire might have further decreased the low
response rate. On the other hand, a detailed analysis of all
diﬀerent pacemaker and ICD device types in selected high-
volume centers showed no clinically relevant interference
between 19/8 types (pacemakers/ICDs) from 7 diﬀerent
brands and PillCam or Endocapsule systems [13].
In this survey, indication for CE was almost exclusively
obscure gastrointestinal bleeding. This is similar to the re-
sults of the 2004 survey but diﬀerent from other series on
caspule endoscopy in unselected patients, where GI bleed-
ing accounted for approximately 66% of indications [14].
Although not included in the questionnaire, it might be sus-
pected that patients with implanted cardiac devices might
be older and more frequently suﬀer from comorbidity and
require anticoagulants and thrombocyte aggregation inhibi-
tors, thus provoking GI bleeding.
Although CE does not seem to inﬂuence cardiac devices
in clinical practice, four clinics report about interference
of CE (artefacts, stopping of recording of the video) after
instillation of telemetry. In a retrospective multicenter inves-
tigation, interference (artefacts, impossibility to document
CE images) between CE and telemetry occurred in two cases
[13]. Reasons for this interference are disturbances on the
same frequency as CE. Many wireless applications use the
frequency of 434MHz (transmission range of CE). Remark-
ably these interferences do not occur permanently. Distur-
bances between CE and telemetry could possibly explain the
interferences with impairment of the CE video in the studies
of Guyomar et al. [15] and Bandorski et al. [3].
Monitoring or tests of the implanted devices before and
after CE were performed only by half of the physicians. Al-
though this fact limits the power of the present study to de-
tect asymptomatic arrhythmias, it demonstrates physicians’
conﬁdence into the safety of CE, thus avoiding presumably
unnecessary precautions or potential disturbance of CE vid-
eos.
Despite of the low response rate in this survey, the
number of included patients with pacemakers and ICDs who
underwent CE increased to 380 compared to 53 in our last
survey in the year 2004. As only three physicians stated in the
2010 survey that they had participated in the 2004 inquiry
(where 28 physicians had performed CE in patients with
cardiac devices), the total number of patients might further
be underestimated.
In spite of limited details provided by the present survey,
this largest cohort of patients with a pacemakers or implant-
ed cardioverter undergoing an uneventful capsule endoscopy
adds further evidence to support its safety.
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